Teradyne (TER) EBT (2009 - 2026)

Teradyne has reported EBT for 18 years, with the latest figure at $465.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 291.25% year-over-year to $465.7 million; the trailing twelve-month figure through Mar 2026 stood at $999.9 million (up 52.61% YoY), and the FY2025 full-year result was $653.3 million, up 7.25% from the prior year.
• EBT for Q1 2026 stood at $465.7 million, up from $289.6 million in the prior quarter.
• The five-year high for EBT was $465.7 million in Q1 2026, with the low at $72.9 million in Q1 2024.
• Historically, EBT has averaged $182.0 million across 5 years, with a median of $157.8 million in 2024.
• Annual changes were most pronounced in 2025 — EBT plunged 55.99% — and 2026, when it jumped 291.25%.
• Teradyne's EBT stood at $195.2 million in 2022, then retreated by 28.39% to $139.8 million in 2023, then advanced by 12.87% to $157.8 million in 2024, then surged by 83.51% to $289.6 million in 2025, then soared by 60.81% to $465.7 million in 2026.
• The last three EBT figures came in at $465.7 million (Q1 2026), $289.6 million (Q4 2025), and $148.1 million (Q3 2025), per Business Quant data.